AHPA Guidance

AHPA guidance documents

AHPA produces these guidance documents on specific topics to help the industry comply with applicable laws and regulations and institute best practices that help ensure quality and transparency.

Additional guidance is available in AHPA's Guidance Policies >>

Guidance on foreign matter limits in herbal ingredients

Guidance recommends plant parts of the same herbal raw material species, other than those named in specifications, should not exceed 5% (by weight), and all other foreign matter should not exceed 2% (by weight)
Good Agricultural Collection Practices and Good Manufacturing Practices for botanical materals

Good Agricultural Collection Practices and Good Manufacturing Practices for botanical materals

Best practices and assessment tools help ensure quality of botanicals at every step of the supply chain

AHPA has developed a set of free assessment tools to help the herbal products industry evaluate and document policies and procedures that ensure high quality herbs and herbal ingredients throughout the supply chain. The assessment tools are designed to be used with AHPA's recently released Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Materials (GACP-GMP).

White paper: Good Herbal Compounding and Dispensing Practices

Best practices for compounding and dispensing herbal formulations

The American Herbal Products Association (AHPA) has issued a white paper to guide qualified practitioners who compound herbal formulations for clients based on one-on-one consultations.

Labeling guidance for fungi products

Guidance becomes effective March 9, 2019

The Board of Trustees of the American Herbal Products Association (AHPA) at its March 9, 2017 meeting authorized issuance of guidance for labeling products that contain fungi ingredients.

AHPA Policy prohibits the sale of bulk caffeine

Recent reports associate serious injury and death with use of pure caffeine purchased by consumers in bulk packaging

The American Herbal Products Association (AHPA) Board of Trustees on March 4 established a trade requirement that prohibits sale by AHPA members of pure caffeine in bulk form at retail (to consumers).

Cannabis oversight recommendations for regulators

September 10, 2014: Oversight framework promotes best practices for cannabis production and distribution from seed to consumption

The American Herbal Products Association (AHPA) has published recommendations for regulators to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species.

AHPA Guidance Policies

These guidance policies are designed to promote the responsible commerce of herbal products.

These policies address a variety of labeling and manufacturing issues and reflect the consensus of AHPA’s members and its board of trustees.

Organoleptic Analysis of Herbal Ingredients

Organoleptic Analysis of Herbal Ingredients

March 2013: A practical guide for organoleptic characterization, with or without macroscopic descriptors, to identify botanical materials

AHPA Members log in to access this document.

Interim Guidance for New Dietary Ingredient (NDI) Notifications for Manufacturers and Distributors

NDI guidance published in May 2006 and revised September 2011 - Log-in to download

This guide explains the new dietary ingredient (NDI) regulations and identifies information to include-and exclude- in an NDI notification

Guidance on Adverse Event Reporting (AER)

Considerations and MedWatch Worksheet for receiving AERs associated with dietary supplements - Log in to download

The information provided here addresses internal policies that may be established by companies in preparation for receiving an adverse event report and also presents ideas for communicating with the reporter of such an event.
RSS
1234

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.